Table 3

Prognostic factors for 5-year DFS and overall survival in multivariate Cox regression analysis

Features

DFS

Overall Survival

HR

95%CI

p-Value

HR

95%CI

p-Value

Age

1.00

0.98–1.01

0.9058

1.04

1.01–1.06

0.0013

Tumor size, cm

1.19

1.10–1.28

<0.0001

1.17

1.04–1.32

0.0110

Lymph node

(Positive vs. Negative)

2.65

1.79–3.92

<0.0001

2.36

1.35–4.12

0.0026

Metastasis

(Yes vs. No)

2.30

1.15–4.64

0.0193

6.63

3.13–14.09

<0.0001

Grade

(III vs. I ~II)

1.54

1.05–2.26

0.0269

2.11

1.23–3.62

0.0065

Tumor subgroups

(TNBC vs. non-TNBC)

1.28

0.82–1.99

0.2835

1.66

0.93–2.96

0.0881

Node-positive

Age

0.99

0.97–1.01

0.2960

1.04

1.01–1.07

0.0161

Tumor size, cm

1.23

1.10–1.37

0.0002

1.29

1.11–1.51

0.0011

Metastasis

(Yes vs. No)

2.37

1.15–4.88

0.0198

7.52

3.37–16.79

<0.0001

Grade

(III vs. I ~II)

1.49

0.93–2.36

0.0948

2.46

1.23–4.90

0.0109

Tumor subgroups

(TNBC vs. non-TNBC)

1.13

0.63–2.03

0.6847

2.20

1.08–4.49

0.0296

Node-negative

Age

1.02

0.99–1.04

0.1801

1.04

1.01–1.07

0.0186

Tumor size, cm

1.16

1.02–1.31

0.0236

1.00

0.74–1.36

0.9813

Metastasis*

(Yes vs. No)

-

-

-

-

-

-

Grade

(III vs. I ~ II)

1.49

0.75–2.94

0.2526

1.69

0.69–4.12

0.2525

Tumor subgroups

(TNBC vs. non-TNBC)

1.52

0.75–3.06

0.2461

1.28

0.47–3.19

0.6815

* Patients without metastasis were censor observations by the end of study period

Lin et al. BMC Cancer 2009 9:192   doi:10.1186/1471-2407-9-192